Allarity Therapeutics Europe ApS
CVR: 34623562
Micro companyWell-established (13 yrs)Loss-making
Secondary names: Oncology Venture Product Development ApS
Active
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 1.8.2012
Details
- Employees
- 6 employees
- 3 FTE
- (2018)
- Capital
- 2.206.593 kr.
Contact
- Phone
- Log in to see
Purpose
Selskabets formål er at investere eller på anden måde være engageret i virksomheder, der beskæftiger sig med diagnostik og lægemiddeludvikling, herunder individualiseret medicin til kræftbehandling. Selskabet kan yde konsulent- og managementbistand til selskaber. The object of the company is to invest or otherwise be engaged in businesses that are involved in diagnostics and development of medicinal products, including individualized medicinal products for the treatment of cancer. The company may offer consultancy and management assistance to other companies.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | -393.8 mio. | 11.2 mio. | -198.8 mio. | 4 | |
History
Ownership
Allarity Therapeutics Europe ApS
CVR: 34623562
Management
Directors
Steen Meier Knudsen(ADM. DIR.)
Jeffrey Stuart Ervin(DIREKTØR)
Founders
Production units (1)
Allarity Therapeutics Europe ApS
P-no: 1017836834
Venlighedsvej 1, 2970, Hørsholm
Fremstilling af farmaceutiske præparater
6 employees
Similar companies
Companies in the same industry and area